UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549

                                  SCHEDULE 13G
                                 (Rule 13d-102)

                    Under the Securities Exchange Act of 1934
                                       ()

                               Moore Medical Corp.
                                (Name of Issuer)

                                  Common Stock
                         (Title of Class of Securities)

                                    615799103
                                 (CUSIP Number)

                                 January 22,2004
             (Date of Event Which Requires Filing of this Statement)

      (1) The remainder of this cover page shall be filled out for a reporting
person's initial filing on this form with respect to the subject class of
securities, and for any subsequent amendment containing information which would
alter disclosures provided in a prior cover page.

      The information required on the remainder of this cover page shall not be
deemed to be "filed" for the purpose of Section 18 of the Securities Exchange
Act of 1934 ("Act") or otherwise subject to the liabilities of that section of
the Act but shall be subject to all other provisions of the Act (however, see
the Notes).


                                Page 1 of 5 Pages


CUSIP No 615799103                    13G
--------------------------------------------------------------------------------
1.   NAME OF REPORTING PERSON
     S. S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON

     TowerView LLC.    Employer I.D.# 13-4159490
--------------------------------------------------------------------------------
2.   CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

                                                                 (a)  |_|
                                                                 (b)  |X|
--------------------------------------------------------------------------------
3.   SEC USE ONLY


--------------------------------------------------------------------------------
4.   CITIZENSHIP OR PLACE OF ORGANIZATION

     State of Delaware
--------------------------------------------------------------------------------
  NUMBER OF    5.   SOLE VOTING POWER

   SHARES           193,500
               -----------------------------------------------------------------
BENEFICIALLY   6.   SHARED VOTING POWER

  OWNED BY          0
               -----------------------------------------------------------------
    EACH       7.   SOLE DISPOSITIVE POWER

  REPORTING         193,500
               -----------------------------------------------------------------
   PERSON      8.   SHARED DISPOSITIVE POWER

    WITH            0
--------------------------------------------------------------------------------
9.   AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     193,500
--------------------------------------------------------------------------------
10.  CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES

                                                                          |_|
--------------------------------------------------------------------------------
11.  PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

     6.0%
--------------------------------------------------------------------------------
12.  TYPE OF REPORTING PERSON

     PN
--------------------------------------------------------------------------------

                      SEE INSTRUCTIONS BEFORE FILLING OUT!


                                Page 2 of 5 Pages


Item 1(a).  Name of Issuer:

            The name of the issuer is Moore Medical Corp. (the "Issuer").

Item 1(b).  Address of Issuer's Principal Executive Offices:

            The Issuer's principal executive offices are located at P.O. Box
            1500 New Britain, CT 06050

Item 2(a).  Name of Person Filing:

            This report is being filed by TowerView LLC (the "Reporting
            Person").

Item 2(b).  Address of Principal Business Office or, if None, Residence:

            The Reporting Person's principal business address is 500 Park
            Avenue, New York, New York 10022.

Item 2(c).  Citizenship:

            The Reporting Person is a Limited Liability Company organized under
            the laws of Delaware.

Item 2(d).  Title of Class of Securities:

            The report covers the Issuer's Common Stock (the "Shares"), $.01
            value.

Item 2(e).  CUSIP Number:

            The CUSIP number of the Shares is 615799103.

Item 3.     If This Statement is Filed Pursuant to Rule 13d-1(b), or 13d-2(b)
            or (c), Check Whether the Person Filing is a:

            (a)     |_| Broker and dealer registered under Section 15 of the
                        Exchange Act.

            (b)     |_| Bank as defined in Section 3(a)(6) of the Exchange Act.

            (c)     |_| Insurance company as defined in Section 3(a)(19) of the
                        Exchange Act.

            (d)     |_| Investment company registered under Section 8 of the
                        Investment Company Act.

            (e)     |_| An investment adviser in accordance with Rule
                        13d-1(b)(1)(ii)(E);

            (f)     |_| An employee benefit plan or endowment fund in accordance
                        with Rule 13d-1(b)(1)(ii)(F);

            (g)     |_| A parent holding company or control person in accordance
                        with Rule 13d-1(b)(1)(ii)(G);

            (h)     |_| A savings association as defined in Section 3(b) of the
                        Federal Deposit Insurance Act;

            (i)     |_| A church plan that is excluded from the definition of an
                        investment company under Section 3(c)(14) of the
                        Investment Company Act;

            (j)     |_| Group, in accordance with Rule 13d-1(b)(1)(ii)(J).


                                Page 3 of 5 Pages


            If this statement is filed pursuant to Rule 13d-1(c), check this
            box. |X|

Item 4.     Ownership

            (a) Amount beneficially owned: As of January 22, 2004 the Reporting
            Person beneficially owned 193,500 shares (the "Shares") of Common
            Stock.

            (b) Percent of class: As of January 20, 2004 the Issuer had
            outstanding 3,200,009 shares of Common Stock. The 193,500 shares of
            Common Stock held beneficially by the Reporting Person represented
            6.0% of the outstanding shares of Common Stock.

            (c) Number of Shares as to which the Reporting Person has:

                  (i)   sole power to vote or direct the vote -- 193,500 shares;

                  (ii)  shared power to vote or to direct the vote -- none;

                  (iii) sole power to dispose or direct the disposition of --
                        193,500 shares; and

                  (iv)  shared power to dispose or to direct the disposition of
                        -- none.

Item 5.     Ownership of Five Percent or Less of a Class

            If this statement is being filed to report the fact that as of the
            date hereof the reporting person has ceased to be the beneficial
            owner of more than five percent of the class of securities, check
            the following |_|.

Item 6.     Ownership of More than Five Percent on Behalf of Another Person

            Not applicable.

Item 7.     Identification and Classification of the Subsidiary Which Acquired
            The Security Being Reported on By The Parent Holding Company

            Not applicable.

Item 8.     Identification and Classification of Members of the Group

            Not applicable.

Item 9.     Notice of Dissolution of Group

            Not applicable.

Item 10.    Certification

            By signing below I certify that, to the best of my knowledge and
            belief, the securities referred to above were not acquired and are
            not held for the purpose of or with the effect of changing or
            influencing the control of the issuer of the securities and were not
            acquired and are not held in connection with or as a participant in
            any transaction having that purpose or effect.


                                Page 4 of 5 Pages


                                    SIGNATURE

      After reasonable inquiry and to the best of my knowledge and belief, I
certify that the information set forth in this statement is true, complete and
correct.

                                                 January 23, 2004
                                                      (Date)


                                                 /s/ Daniel R. Tisch
                                        ------------------------------------
                                                     (Signature)

                                        Daniel R. Tisch
                                        Authorized Signatory
                                        TowerView LLC
                                        ------------------------------------
                                                    (Name/Title)


                                Page 5 of 5 Pages